Algeta Appoints Andrew Kay as President and Chief Executive Officer
OSLO, December 11 /PRNewswire/ --
- Appointment Enhances Algeta's Commercial Capabilities and Aims to Accelerate Further Development of Alpharadin in Advanced Prostate Cancer
Algeta ASA (OSE: ALGETA…